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Introduction: Herpes zoster is a well-known reactivating viral disease that gives rise to painful skin lesions. Although
this vesicular rash heals up within a few weeks, pain sometimes continues, becoming postherpetic neuralgia. In the
case of those at high risk of developing postherpetic neuralgia, early interventional pain management is generally
recommended as a preventive measure. Pain specialists usually do not see patients face-to-face for chronic refractory
pain until the stage of postherpetic neuralgia. However, active and aggressive management, including antiviral
treatment, of herpetic neuralgia during the acute stage of herpes zoster promises better results. In this respect,
superficial cervical plexus block can help patients, such as the case reported here, by relieving the pain of herpes
zoster involving the C3 dermatome.
Case presentation: A 65-year-old Korean man with severe pain in his left C3 dermatome due to herpes zoster
was admitted to our hospital. His pain was so refractory to medication that he consulted our pain clinic for pain
control. Due to the medication limitations imposed by his underlying diseases (hepatitis B, liver cirrhosis, atrial
fibrillation, and asthma), early interventional therapy including stellate ganglion block was planned. In addition,
because his painful C3 dermatome overlapped significantly with the superficial cervical plexus dermatome,
ultrasound-guided superficial cervical plexus block was utilized for pain control of the intractable herpes zoster
neuritis in his C3 dermatome. The result with respect to his sporadic neuralgia was satisfactory.
Conclusions: We found superficial cervical plexus block to be an effective interventional procedure for pain
management of herpes zoster, particularly at the C3-dermatomal level.
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Herpes zoster (HZ) is a disease caused by reactivation of
the varicella zoster virus (VZV) after initial presentation
as chickenpox under conditions such as old age, malig-
nancy, diabetes, and immunosuppressive therapy with/
without steroids [1-3]. The median duration of illness is
7 to 10 days. Prodromal pain usually occurs unilaterally
according to the involved dermatome. After 2 to 3 days
of pain characterized by a burning or tingling sensation,
erythematous maculopapular rashes appear and rapidly
progress to vesicles. As the lesions dry, they become
crusts, and typically peel away 3 to 5 days after their* Correspondence: pain2012@daum.net
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reproduction in any medium, provided the orappearance. Recovery of normal skin in some cases takes
several weeks. However, regardless of skin lesions, pain
can persist and develop into postherpetic neuralgia
(PHN). For this reason, it is important that early pain
management be aggressive [2,4]. For patients at high risk
of PHN, interventional management involving nerve
block and other treatments together with medication is
recommended [4]. Here we report the first known case
of a patient with HZ neuritis involving the C3 derma-
tome who was effectively treated with superficial cervical
plexus (SCP) block under ultrasound guidance.
Case presentation
A 63-year-old Korean man with HZ presented at our
hospital’s emergency room and was admitted to the der-
matologic ward due to intractable medication-resistantd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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various conditions stemming from a history of atrial fib-
rillation, asthma, hepatitis B and liver cirrhosis. He had
visited an otolaryngologic clinic for auricular pain that
had arisen after a cold, although no ear abnormalities
were found, 12 days before admission. Then, 2 days later,
erythematous maculopapular rashes appeared in the
painful area; subsequently, he was diagnosed with HZ
and started on medications including antiviral agents.
His skin lesions improved (excepting some vesicles) by
degrees and crusts formed. Nevertheless, combined itch-
ing, stabbing and throbbing pain on the left of his neck
and postauricular area did not improve. Just before he
came to the emergency room, the throbbing pain had
worsened considerably, manifesting itself at intervals of
2 to 3 hours despite medication. Finally, he was hospitalized
due to refractory HZ neuralgia. Medication including non-
steroidal anti-inflammatory drugs, anticonvulsant (gabapen-
tin, 600mg/day), antidepressants (amitriptyline, 10mg/day)
and antibiotics was administered for alleviation of his symp-
toms, and he later consulted our pain clinic for pain control.
On physical examination at our pain clinic, he showed
skin lesions with crusts mixed with some vesicles in the
left C3 dermatome (that is, the left of his neck and post-
auricular area). The accompanying pain was continu-
ously throbbing and burning in nature; shooting pain,
additionally, was sporadic and intermittent. The intensity
of his continuous pain registered six on the 11-point
Numeric Rating Scale (NRS), and his intermittent pain,
eight. It presented with allodynia and hyperalgesia. He
also had pain-related sleep disturbance. The laboratory
evaluation revealed a normal coagulation profile with a
platelet count of more than 100,000/μL.
We performed stellate ganglion block (SGB) on the
left of his neck, recommended augmented doses ofFigure 1 Stellate ganglion block for effective treatment of neuralgia i
branches of the superficial cervical plexus. (B) The patient’s skin lesion with
sternocleidomastoid; SCPB, superficial cervical plexus block.gabapentin (to 1200mg/day) and amitriptyline (to 20mg/
day), and prescribed EMLA® cream (a cream containing
a eutectic mixture of local anesthetics: lidocaine and pri-
locaine). The following day, his pain was sufficiently alle-
viated to enable sleep. Routine laboratory findings
included abnormal liver and renal function test data
considered to have resulted from the patient’s underlying
diseases. He was transferred to the Department of In-
ternal Medicine and prescribed half doses of gabapentin
(600mg/day) and amitriptyline (10mg/day). On the basis
of his clinical condition, we administered intravenous
patient-controlled analgesia (PCA) with fentanyl, and re-
peated the SGB four times at intervals of 2 or 3 days.
Notwithstanding the gradual improvement of his symp-
toms, sporadic neuralgia, seemingly quite centralized in
the dermatome of the SCP (Figure 1), still bothered him
at dawn. In addition to the SGB, we performed
ultrasound-guided SCP block with 6mL of 0.125% ropi-
vacaine and 10mg of triamcinolone acetonide, after
which his throbbing dawn pain disappeared. His NRS
score fell to three through the course of the pain man-
agement. However, his allodynia and hyperalgesia did
not quickly or significantly improve. About 10 days after
starting the PCA, on the fifth day following the SCP
block, he requested its discontinuance. The total num-
bers of SGB and SCP block applications were six and
one, respectively, during his hospitalization.
Discussion
HZ presenting as pain and characteristic skin lesions can
become PHN although the skin lesions heal up. PHN
manifests as continued intractable neuropathic pain in
conjunction with abnormal sensation. High-risk factors
for development of PHN include old age, severe acute
pain, severe rash, prodromal symptoms of intense pain,nvolving the C3 dermatome. (A) An illustration of the four terminal
the neuralgia due to herpes zoster. Abbreviations: SCM,
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socioeconomic burden, reduces the patient’s quality of
life. For all of these reasons, early aggressive manage-
ment is strongly emphasized and recommended [2,5-8].
In diagnosing HZ, there are five symptoms to particu-
larly watch out for: painful prodrome, unilateral derma-
tome involvement, vesiculopapular skin lesions, a history
of rash in the same area, and skin lesion pain manifest-
ing as allodynia [8]. Early diagnosis of HZ is extremely
difficult at the prodromal stage lacking pathognomonic
skin lesions; as such HZ is sometimes misdiagnosed as
other diseases (for example appendicitis, myocardial in-
farction, renal colic, cholelithiasis, and so on) [4,6]. The
commonly involved dermatomes range from T3 to L3.
The fact that vesiculopapular skin lesions usually occur
in these specific unilateral dermatomes is helpful to the
diagnosis of HZ. If skin lesions are not definite, the high-
est sensitivity and highest specificity diagnostic tool for
confirmation of VZV deoxyribonucleic acid (DNA) is
polymerase chain reaction, which can be alternated with
direct immunofluorescence assay [4]. In our present
case, the patient with HZ involving the C3 dermatome, a
less affected region, complained first only of a unilateral
periauricular stinging pain, having no skin lesions, and
thus could not easily be diagnosed with early stage HZ.
Only once the C3 dermatomal rash was revealed could
he be accurately diagnosed and treated for HZ with
refractory pain.
For effective treatment of HZ, the antiviral agent must
be prescribed within 48 to 72 hours to reduce the pain/
skin lesion duration and PHN rate, particularly with el-
derly patients or patients who are immunodepressed.
Even beyond 72 hours of rash onset, an antiviral agent,
together with steroids, analgesics, antidepressants and so
on, is recommended. The aforementioned high-risk
group for development of PHN requires early and ag-
gressive pain management with interventional therapy
and medication. Interventions contain epidural block,
sympathetic nervous system block, and nerve root or
peripheral nerve block. Nerve blocks have shown effect-
ive pain control and even PHN prevention in some cases
of acute HZ involving acute pain [2,4,7,9]. If the employed
intervention is effective, it is repeated until pain is mark-
edly improved; if not, then other interventions (that is,
sympathetic neurolysis, spinal cord stimulation, peripheral
nerve stimulation, pulsed radiofrequency lesioning or ra-
diofrequency thermocoagulation of the dorsal root gan-
glion). Even though a number of methods, including those
noted above, have been proposed, personalized or tailored
treatment in consideration of specific effectiveness and
prognosis is best [2,4,10]. Among the effective interven-
tional therapies, SGB, a type of sympathetic nervous
system blockade, can help to reduce HZ pain above
the T3-dermatome level as a result of interactionbetween the sympathetic nervous system and the dam-
aged nerve [2-4,10,11]. In the present case, the initial
SGB procedure allowed our patient to sleep well at
night, and was administered at least three times per
week. Allodynia and hyperalgesia with sporadic throb-
bing pain localized in the C3 dermatome on the left of
his neck remained, despite considerable overall allevi-
ation of his pain. Regardless, his symptomatic area cor-
responded so completely with the SCP domain that a
SCP block was planned. The SCP emerges from the
anterior rami of the C1 to C4 dermatomes and leads to
four terminal branches: the greater auricular nerve, the
lesser occipital nerve, the transverse cervical nerve,
and the supraclavicular nerve. The greater auricular
nerve is the largest branch in the distribution of the
anterior and posterior parts of the auricles; the lesser
occipital nerve extends to the superior posterior neck
and scalp behind the auricle; the transverse cervical
nerve traverses the anterolateral territory of the neck
from the sternum to the mandible; and the supraclavi-
cular nerve separates into three branches supplying the
cape of the neck and shoulder to the second intercostal
level (Figure 1A).
We performed a SCP block at the level of the cricoid
cartilage toward the hyperechoic fascia with reference to
the posterior border of the sternocleidomastoid muscle,
by the ultrasound-guided posterior in-plane approach
using a linear high-frequency transducer and real-time
assessment. At the target site, 6mL of 0.125% ropiva-
caine was injected with a 25G needle; it was enough for
a successful blockage [12]. From the first day of the
blockade, the sporadic throbbing and shooting pain
completely disappeared; this outcome was highly satis-
factory to the patient (Figure 1B).
Conclusions
Whereas SGB is an interventional modality that is often
employed, instances of its combination with SCP block
in the treatment of HZ involving the C3 dermatome are
almost unprecedented. Thus, we suggest that in cases
where patients complain of periauricular pain without
lesions or other apparent origin, there is a need to rule
out the possibility of prodromal-phase HZ involving the
C3 dermatome. Also, on the basis of the results of this
case report, we recommend SCP block as a potentially
very effective, minimally invasive and ultrasound-guidable
treatment option for the control of intractable pain corre-
sponding to the distribution of the SCP.
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